Prolonged tamoxifen exposure selects a breast cancer cell clone that is stable in vitro and in vivo

Pirkko E H Sipila, Valerie J. Wiebe, Gene B. Hubbard, Steven K. Koester, Vernon D. Emshoff, Juhani U. Maenpaa, Gregory T. Wurz, Robert C. Seymour, Michael W. DeGregorio

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The effects of long-term tamoxifen exposure on cell growth and cell cycle kinetics were compared between oestrogen receptor (ER)-positive (MCF-7) and ER-negative (MDA-MB-231) cell lines. In the MCF-7 cell line, prolonged tamoxifen exposure (0.5 μmol/l for > 100 days) blocked cells in G0-G1 of the cell cycle, and slowed the doubling time of cells from 30 to 59 h. These effects corresponded to an increase in the cellular accumulation of tamoxifen over time [mean area under concentration curve (AUC) = 77.92 μmoles/106/cells/day]. In contrast, in the MDA-MB-231 cell line, long-term tamoxifen exposure had no obvious effect on the doubling time, and reduced cellular tamoxifen accumulation (mean AUC = 50.50 μmoles/106/cells/day) compared to the MCF-7 cells. Flow cytometric analysis of MDA-MB-231 cells demonstrated that a new tetraploid clone emerged following 56 days of tamoxifen exposure. Inoculation of the MDA-MB-231 tetraploid clone and MDA-MB-231 wildtype cells into the opposite flanks of athymic nude mice resulted in the rapid growth of tetraploid tumours. The tetraploid tumours maintained their ploidy following tamoxifen treatment for nine consecutive serial transplantations. Histological examination of the fifth transplant generation xenografts revealed that the tetraploid tumour had a 25-30 times greater mass, area of haemorrhage and necrosis, a slightly higher mitotic index and was more anaplastic than the control neoplasm. The control wildtype MDA-MB-231 tumours maintained a stable ploidy following tamoxifen treatment until the eighth and ninth transplantation, when a tetraploid population appeared, suggesting that tamoxifen treatment may select for this clone in vivo. These studies suggest that prolonged tamoxifen exposure may select for new, stable, fast growing cell clones in vitro as well as in vivo.

Original languageEnglish (US)
Pages (from-to)2138-2144
Number of pages7
JournalEuropean Journal of Cancer
Volume29
Issue number15
DOIs
StatePublished - 1993
Externally publishedYes

Fingerprint

Tamoxifen
Clone Cells
Tetraploidy
Breast Neoplasms
Ploidies
MCF-7 Cells
Neoplasms
Nude Mice
Cell Line
Area Under Curve
Cell Cycle
Transplantation
In Vitro Techniques
Mitotic Index
Growth
Heterografts
Estrogen Receptors
Necrosis
Hemorrhage
Transplants

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Sipila, P. E. H., Wiebe, V. J., Hubbard, G. B., Koester, S. K., Emshoff, V. D., Maenpaa, J. U., ... DeGregorio, M. W. (1993). Prolonged tamoxifen exposure selects a breast cancer cell clone that is stable in vitro and in vivo. European Journal of Cancer, 29(15), 2138-2144. https://doi.org/10.1016/0959-8049(93)90049-L

Prolonged tamoxifen exposure selects a breast cancer cell clone that is stable in vitro and in vivo. / Sipila, Pirkko E H; Wiebe, Valerie J.; Hubbard, Gene B.; Koester, Steven K.; Emshoff, Vernon D.; Maenpaa, Juhani U.; Wurz, Gregory T.; Seymour, Robert C.; DeGregorio, Michael W.

In: European Journal of Cancer, Vol. 29, No. 15, 1993, p. 2138-2144.

Research output: Contribution to journalArticle

Sipila, PEH, Wiebe, VJ, Hubbard, GB, Koester, SK, Emshoff, VD, Maenpaa, JU, Wurz, GT, Seymour, RC & DeGregorio, MW 1993, 'Prolonged tamoxifen exposure selects a breast cancer cell clone that is stable in vitro and in vivo', European Journal of Cancer, vol. 29, no. 15, pp. 2138-2144. https://doi.org/10.1016/0959-8049(93)90049-L
Sipila, Pirkko E H ; Wiebe, Valerie J. ; Hubbard, Gene B. ; Koester, Steven K. ; Emshoff, Vernon D. ; Maenpaa, Juhani U. ; Wurz, Gregory T. ; Seymour, Robert C. ; DeGregorio, Michael W. / Prolonged tamoxifen exposure selects a breast cancer cell clone that is stable in vitro and in vivo. In: European Journal of Cancer. 1993 ; Vol. 29, No. 15. pp. 2138-2144.
@article{3a1a4438b4464be2938d969b051e116b,
title = "Prolonged tamoxifen exposure selects a breast cancer cell clone that is stable in vitro and in vivo",
abstract = "The effects of long-term tamoxifen exposure on cell growth and cell cycle kinetics were compared between oestrogen receptor (ER)-positive (MCF-7) and ER-negative (MDA-MB-231) cell lines. In the MCF-7 cell line, prolonged tamoxifen exposure (0.5 μmol/l for > 100 days) blocked cells in G0-G1 of the cell cycle, and slowed the doubling time of cells from 30 to 59 h. These effects corresponded to an increase in the cellular accumulation of tamoxifen over time [mean area under concentration curve (AUC) = 77.92 μmoles/106/cells/day]. In contrast, in the MDA-MB-231 cell line, long-term tamoxifen exposure had no obvious effect on the doubling time, and reduced cellular tamoxifen accumulation (mean AUC = 50.50 μmoles/106/cells/day) compared to the MCF-7 cells. Flow cytometric analysis of MDA-MB-231 cells demonstrated that a new tetraploid clone emerged following 56 days of tamoxifen exposure. Inoculation of the MDA-MB-231 tetraploid clone and MDA-MB-231 wildtype cells into the opposite flanks of athymic nude mice resulted in the rapid growth of tetraploid tumours. The tetraploid tumours maintained their ploidy following tamoxifen treatment for nine consecutive serial transplantations. Histological examination of the fifth transplant generation xenografts revealed that the tetraploid tumour had a 25-30 times greater mass, area of haemorrhage and necrosis, a slightly higher mitotic index and was more anaplastic than the control neoplasm. The control wildtype MDA-MB-231 tumours maintained a stable ploidy following tamoxifen treatment until the eighth and ninth transplantation, when a tetraploid population appeared, suggesting that tamoxifen treatment may select for this clone in vivo. These studies suggest that prolonged tamoxifen exposure may select for new, stable, fast growing cell clones in vitro as well as in vivo.",
author = "Sipila, {Pirkko E H} and Wiebe, {Valerie J.} and Hubbard, {Gene B.} and Koester, {Steven K.} and Emshoff, {Vernon D.} and Maenpaa, {Juhani U.} and Wurz, {Gregory T.} and Seymour, {Robert C.} and DeGregorio, {Michael W.}",
year = "1993",
doi = "10.1016/0959-8049(93)90049-L",
language = "English (US)",
volume = "29",
pages = "2138--2144",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Limited",
number = "15",

}

TY - JOUR

T1 - Prolonged tamoxifen exposure selects a breast cancer cell clone that is stable in vitro and in vivo

AU - Sipila, Pirkko E H

AU - Wiebe, Valerie J.

AU - Hubbard, Gene B.

AU - Koester, Steven K.

AU - Emshoff, Vernon D.

AU - Maenpaa, Juhani U.

AU - Wurz, Gregory T.

AU - Seymour, Robert C.

AU - DeGregorio, Michael W.

PY - 1993

Y1 - 1993

N2 - The effects of long-term tamoxifen exposure on cell growth and cell cycle kinetics were compared between oestrogen receptor (ER)-positive (MCF-7) and ER-negative (MDA-MB-231) cell lines. In the MCF-7 cell line, prolonged tamoxifen exposure (0.5 μmol/l for > 100 days) blocked cells in G0-G1 of the cell cycle, and slowed the doubling time of cells from 30 to 59 h. These effects corresponded to an increase in the cellular accumulation of tamoxifen over time [mean area under concentration curve (AUC) = 77.92 μmoles/106/cells/day]. In contrast, in the MDA-MB-231 cell line, long-term tamoxifen exposure had no obvious effect on the doubling time, and reduced cellular tamoxifen accumulation (mean AUC = 50.50 μmoles/106/cells/day) compared to the MCF-7 cells. Flow cytometric analysis of MDA-MB-231 cells demonstrated that a new tetraploid clone emerged following 56 days of tamoxifen exposure. Inoculation of the MDA-MB-231 tetraploid clone and MDA-MB-231 wildtype cells into the opposite flanks of athymic nude mice resulted in the rapid growth of tetraploid tumours. The tetraploid tumours maintained their ploidy following tamoxifen treatment for nine consecutive serial transplantations. Histological examination of the fifth transplant generation xenografts revealed that the tetraploid tumour had a 25-30 times greater mass, area of haemorrhage and necrosis, a slightly higher mitotic index and was more anaplastic than the control neoplasm. The control wildtype MDA-MB-231 tumours maintained a stable ploidy following tamoxifen treatment until the eighth and ninth transplantation, when a tetraploid population appeared, suggesting that tamoxifen treatment may select for this clone in vivo. These studies suggest that prolonged tamoxifen exposure may select for new, stable, fast growing cell clones in vitro as well as in vivo.

AB - The effects of long-term tamoxifen exposure on cell growth and cell cycle kinetics were compared between oestrogen receptor (ER)-positive (MCF-7) and ER-negative (MDA-MB-231) cell lines. In the MCF-7 cell line, prolonged tamoxifen exposure (0.5 μmol/l for > 100 days) blocked cells in G0-G1 of the cell cycle, and slowed the doubling time of cells from 30 to 59 h. These effects corresponded to an increase in the cellular accumulation of tamoxifen over time [mean area under concentration curve (AUC) = 77.92 μmoles/106/cells/day]. In contrast, in the MDA-MB-231 cell line, long-term tamoxifen exposure had no obvious effect on the doubling time, and reduced cellular tamoxifen accumulation (mean AUC = 50.50 μmoles/106/cells/day) compared to the MCF-7 cells. Flow cytometric analysis of MDA-MB-231 cells demonstrated that a new tetraploid clone emerged following 56 days of tamoxifen exposure. Inoculation of the MDA-MB-231 tetraploid clone and MDA-MB-231 wildtype cells into the opposite flanks of athymic nude mice resulted in the rapid growth of tetraploid tumours. The tetraploid tumours maintained their ploidy following tamoxifen treatment for nine consecutive serial transplantations. Histological examination of the fifth transplant generation xenografts revealed that the tetraploid tumour had a 25-30 times greater mass, area of haemorrhage and necrosis, a slightly higher mitotic index and was more anaplastic than the control neoplasm. The control wildtype MDA-MB-231 tumours maintained a stable ploidy following tamoxifen treatment until the eighth and ninth transplantation, when a tetraploid population appeared, suggesting that tamoxifen treatment may select for this clone in vivo. These studies suggest that prolonged tamoxifen exposure may select for new, stable, fast growing cell clones in vitro as well as in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0027433012&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027433012&partnerID=8YFLogxK

U2 - 10.1016/0959-8049(93)90049-L

DO - 10.1016/0959-8049(93)90049-L

M3 - Article

C2 - 8297653

AN - SCOPUS:0027433012

VL - 29

SP - 2138

EP - 2144

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 15

ER -